October 17th 2025
The AI-enabled LungQ® 4 software reportedly offers enhanced segmentation of peripheral airways and estimates of chronic perfusion deficits based on analysis of chest CT scans.
Study Suggests the COVID-19 Pandemic Led to Millions of Decreased Cancer Screenings
June 6th 2022A new survey study from the American Cancer Society shows a 4.47 million decrease in cervical cancer screenings and a 2.13 million decrease in breast cancer screenings in the United States between 2018 and 2020.
Lessons Learned from the Iodinated Contrast Media Shortage: A Neuroradiologist's Perspective
June 3rd 2022In a recent video interview on the current iodinated contrast media shortage, neuroradiologist Sean Bryant, MD discussed imaging alternatives, emphasized communication with referring physicians on optimal studies, and discussed the ongoing need to prevent “protocol creep” with timely updates of imaging protocols.
Can Diffusion-Weighted MRI Have an Impact in Detecting Recurrent Pancreatic Cancer?
May 29th 2022For post-op monitoring of patients who had pancreatic ductal adenocarcinoma (PDAC) resection, a new study showed that diffusion-weighted magnetic resonance imaging (MRI) had enhanced sensitivity for detecting recurrent tumors in comparison to conventional MRI.
AI May Bolster Assessment of Pulmonary Nodules on Chest CT
May 24th 2022A new study revealed that an emerging artificial intelligence (AI)-enabled software tool led to improved sensitivity, specificity and inter-observer agreement for the diagnosis of indeterminate pulmonary nodules on chest computed tomography (CT) scans.
Emerging Strategies for Managing the Acute Shortage of Iodinated Contrast Media
May 18th 2022In a recent video interview, two radiology professors from the Yale School of Medicine discussed the impact of the iodinated contrast media (ICM) shortage and potential strategies, ranging from ICM dose reduction to possible deferment of non-urgent imaging, that may provide a viable path moving forward.
Emerging Perspectives on Computed Tomography Colonography
May 13th 2022In recent video interviews, Syam Reddy, MD, Judy Yee, MD and Anand Narayan, MD, discussed various benefits of computed tomography colonography (CTC) for colorectal cancer screening, the underutilization of the CTC procedure and steps moving forward to improve access to this procedure.
Iodinated Contrast Media: 15 Recommendations for Addressing the Shortage
May 12th 2022Given the challenges with the shortage of the iodinated contrast agent Omnipaque, national and state organizations have issued suggested risk mitigation and conservation strategies to reprioritize imaging needs during this temporary shortage.
New Study Shows Impact of COVID-19 and Comorbidities in Inner-City Lung Screening Cohort
May 1st 2022In a lung screening cohort of over 2,500 people, researchers found that significantly higher rates of chronic kidney disease and chronic heart failure were associated with increased hospitalization and mortality rates in patients with COVID-19.
'A Call to Arms' for Electronic Transfer of Medical Images Between Institutions
April 12th 2022In a recent video interview, Arun Krishnaraj, MD, MPH and David Larson, MD, MBA, discussed the continued use of physical media to transport medical images between different health-care facilities, resulting inefficiencies and delays with patient care, and the initiative to create a linked multi-hub model to end this dated practice once and for all.
ACR Urges CMS to Reconsider Non-Coverage of Computed Tomography Colonography (CTC)
April 7th 2022In a formal request to the Centers for Medicare and Medicaid Services (CMS), the American College of Radiology (ACR) emphasized that Medicare and Medicaid coverage of computed tomography colonography (CTC) could significantly improve colorectal cancer screening rates for at-risk populations.
CMS Expands Medicare Eligibility for CT Lung Cancer Screening
February 15th 2022In a new national coverage determination, the Centers for Medicare and Medicaid Services (CMS) have lowered the starting thresholds for lung cancer screening from 55 to 50 years of age and from a 30-pack/year tobacco smoking history to 20 packs a year.